EN
e-Shop
Find A Doctor
Request an Appointment
International Patient
Emergency Contact
Hospitals
Specialties & Packages
Our Services
Health Hub
Patients & Visitors
Fatty liver disease, or hepatic steatosis, is a condition marked by the accumulation of excess fat in the liver. While many individuals experience no symptoms, some may feel fatigue or discomfort in the upper right abdomen. Left untreated, fatty liver disease can lead to serious complications such as liver fibrosis, cirrhosis, or even liver failure.
The condition is often associated with poor dietary habits, sedentary lifestyles, excessive alcohol intake, and certain medical conditions or medications. Fortunately, fatty liver disease can often be managed—and even reversed—through healthy lifestyle adjustments including a balanced diet, regular exercise, weight management, and reduced alcohol consumption.
Early detection and intervention are essential to prevent long-term liver damage. At Gleneagles Hospitals, our team is committed to supporting you in protecting and maintaining your liver health.
Fatty liver disease occurs when fat builds up in the liver cells. It is generally categorised into two types:
The liver plays a crucial role in regulating blood sugar levels, processing nutrients, and filtering toxins. When excess fat accumulates in the liver, these functions are disrupted, leading to broader metabolic issues.
Type 2 diabetes significantly increases the risk of developing fatty liver disease, particularly NAFLD. This connection is driven by insulin resistance—a condition in which the body does not respond effectively to insulin, resulting in higher levels of insulin in the bloodstream. This, in turn, promotes fat storage in the liver.
In individuals with diabetes, fat from adipose tissue often breaks down and travels to the liver, compounding fat accumulation. Chronic inflammation caused by insulin resistance further damages liver cells and raises the likelihood of progression to more serious liver conditions such as non-alcoholic steatohepatitis (NASH).
Obesity, which frequently coexists with diabetes, worsens insulin resistance and increases fat storage in the liver. Other components of metabolic syndrome—such as high blood pressure, elevated cholesterol, and abdominal obesity—further amplify the risk.
Effective diabetes management through medication, nutrition, and physical activity can significantly reduce the risk of fatty liver disease and support overall liver function.
Improving fatty liver disease requires a holistic approach. Below are five practical and evidence-based strategies:
Choose a diet rich in whole grains, lean proteins, fruits, and vegetables. Avoid processed foods, excessive sugar, and trans fats to prevent further fat accumulation and promote insulin sensitivity.
Gradual and consistent weight loss is beneficial. Shedding as little as 5% to 10% of body weight can significantly reduce liver fat and inflammation. Rapid weight loss, however, should be avoided as it may worsen liver conditions.
As alcohol places additional strain on the liver, it is advisable to reduce or eliminate alcohol consumption—especially for individuals already living with fatty liver disease.
Incorporate at least 150 minutes of moderate aerobic activity weekly. Exercise helps reduce liver fat, improves insulin response, and supports cardiovascular health.
Chronic conditions such as diabetes, high cholesterol, and hypertension should be carefully managed through lifestyle measures and medication as needed. Doing so helps lower liver stress and prevent disease progression.
Adequate hydration and medical supervision further enhance liver function and aid in overall recovery. Personalised care is crucial in tailoring an approach that suits your individual health profile.
If you suspect you may have fatty liver disease or are managing conditions such as diabetes that increase your risk, seeking timely medical care is crucial. Gleneagles Hospitals is dedicated to providing you with expert assessment, tailored treatment, and comprehensive support throughout your health journey.
Take the first step towards protecting your health—book an appointment via our website or through the MyHealth360 application, available on the Google Play Store and the Apple App Store.
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021). Role of Insulin Resistance in NAFLD. International Journal of Molecular Sciences, 22(8), 4156. https://doi.org/10.3390/ijms22084156
2.Bhatt, H. B., & Smith, R. J. (2015). Fatty liver disease in diabetes mellitus. Hepatobiliary surgery and nutrition, 4(2), 101–108. https://doi.org/10.3978/j.issn.2304-3881.2015.01.03
3.Godoy-Matos, A. F., Silva Júnior, W. S., & Valerio, C. M. (2020). NAFLD as a continuum: From obesity to metabolic syndrome and diabetes. Diabetology & Metabolic Syndrome, 12(1). https://doi.org/10.1186/s13098-020-00570-y
4.Nogueira, J. P., & Cusi, K. (2024). Role of insulin resistance in the development of nonalcoholic fatty liver disease in people with type 2 diabetes: From bench to Patient Care. Diabetes Spectrum, 37(1), 20–28.https://doi.org/10.2337/dsi23-0013
5.Patel, S. (n.d.). Inflammation linked to insulin resistance and fatty liver disease. UT Southwestern Medical Center. https://physicianresources.utswmed.org/news/inflammation-linked-to-insulin-resistance-and-fatty-liver-disease?utm6.
6. Ziolkowska, S., Binienda, A., Jabłkowski, M., Szemraj, J., & Czarny, P. (2021, October 15). The interplay between insulin resistance, inflammation, oxidative stress, base excision repair and metabolic syndrome in nonalcoholic fatty liver disease. International journal of molecular sciences.https://pmc.ncbi.nlm.nih.gov/articles/PMC8537238/?utm
Wait a minute
